From the databaseWhat the row says.
Every entry follows the same shape: what is happening, the mechanism, and the recommendation.
Scope
Supplement × Supplement
Last verified
June 4, 2026
CautionEmerging evidence
What is happening. Both fucoxanthin and berberine may lower blood glucose. Berberine has well-documented hypoglycemic activity in humans, and fucoxanthin shows glucose-lowering signals in preclinical and limited clinical data, so the combination could produce additive reductions in blood sugar.
Mechanism. Additive glucose-lowering effects: berberine activates AMPK and improves insulin sensitivity, while fucoxanthin may enhance GLUT4-mediated glucose uptake and insulin sensitivity.
Recommendation. If combining, monitor blood glucose, especially in people who also take antidiabetic medication, and watch for symptoms of hypoglycemia. Adjust under clinical supervision if low readings occur.
Stack Score
How it moves the number.
Effect on the composite score
If both Berberine and Fucoxanthin are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.
SourcesSources, by evidence tier.
Every claim on this page is cited. PMIDs link straight to PubMed.
Reference material
2- 1Yin J, et al. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008.Needs sourceNo link
- 2Maeda H, et al. Anti-obesity and anti-diabetic effects of fucoxanthin on diet-induced obesity. Mol Med Rep. 2009.Needs sourceNo link